SynthesisFrontiers in oncology2025

Comparative safety and efficacy of tislelizumab-based regimens versus chemotherapy in lung cancer: a systematic review and meta-analysis.

Aman Ullah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.